NCT01506752View on ClinicalTrials.gov

A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions

Healthy Adult

Interventions

DRUG

Donepezil Hydrochloride

improved orally disintegrating E2020 10 mg tablet without water.

DRUG

Donepezil Hydrochloride

current orally disintegrating E2020 10 mg tablet without water.

DRUG

Donepezil Hydrochloride

improved orally disintegrating E2020 10 mg tablet with water.

DRUG

Donepezil Hydrochloride

current orally disintegrating E2020 10 mg tablet with water

Trial Locations (1)

Unknown

Sumida-ku

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY

NCT01506752 - A Bioequivalence Study Comparing Improved Versus Current Orally Disintegrating E2020 10 mg Tablet in Healthy Japanese Adult Males | Biotech Hunter | Biotech Hunter